🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to determine and compare the minimum time r...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-06
Trial ID
NCT00644956
Treatments Being Tested
The investigator hypothesizes that treatment with the ß3 agonist mirabegron...
Status
Recruiting
Location
University of Kentucky
Start Date
2021-12-13
Trial ID
NCT05051436
Treatments Being Tested
The primary objective of this study is to determine whether the use of PDE5...
Status
Terminated
Location
Greider Eye Associates
Start Date
2009-07-13
Trial ID
NCT00867815
Treatments Being Tested
to assess the effect of early tadalafil 5 mg once daily on persistent stora...
Status
Completed
Location
Elsayed Abdelhalim Elsayed
Start Date
2021-05-01
Trial ID
NCT06788704
Treatments Being Tested
Sitaxsentan has a low drug-drug interaction potential and it did not have a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01244620
Treatments Being Tested
To address the effect of tadalafil (Cialis) on the cardiovascular system of...
Status
Completed
Location
Health Sciences Centre Rehabilitation Hospital
Start Date
2009-10
Trial ID
NCT01067391
To investigate the long-term safety and effectiveness of Adcirca (tadalafil...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01066845
Treatments Being Tested
This is a randomized, open-label, single-dose, five-period crossover, relat...
Status
Unknown
Location
Multiple Locations
Start Date
2025-05-01
Trial ID
NCT04762082
Treatments Being Tested
This study is a multi-center, prospective, randomized, double blind, placeb...
Status
Terminated
Location
Heart Center Inc - Research
Start Date
2013-11
Trial ID
NCT01910389
Treatments Being Tested
A double-blind placebo controlled study * To compare the effect of tadalaf...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00274430
Treatments Being Tested